Results 21 to 30 of about 1,923,312 (279)

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

The Lancet, 2022
Measures to reduce transmission of SARS-CoV-2 have also been effective in reducing the transmission of other endemic respiratory viruses. As many countries decrease the use of such measures, we expect that SARS-CoV-2 will circulate with other respiratory
M. Swets, C. Russell, E. Harrison, A. Docherty, Nazir Lone, M. Girvan, H. Hardwick, L. Visser, P. Openshaw, G. Groeneveld, M. Semple, J. Baillie   +11 more
semanticscholar   +1 more source

Respiratory Syncytial Virus Symptomatic Fraction, Shedding and Detection in Children Aged 6–23 Months in South Africa in 2022 [PDF]

Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
ABSTRACT Background Accurate detection of RSV infections is important to understand epidemiology. We estimated symptomatic fraction and shedding duration of reverse‐transcription polymerase chain reaction (RT‐PCR)‐confirmed cases and compared RSV detection through molecular and serologic techniques. Methods We enrolled healthy children aged 6–23 months
Cheryl Cohen, Mignon du Plessis, Neil Martinson, Jocelyn Moyes, Sibongile Walaza, Nicole Wolter, Mvuyo Makhasi, Fahima Moosa, Myrna Charles, Aaron M. Samuels, Stefano Tempia, Tumelo Moloantoa, Bekiwe Ncwana, Louisa Phalatse, Lorens Maake, Amelia Buys, Caitlyn Labuschagne, Cayla Reddy, Wilhelmina Ubbink, Nokuthula Linda, Eva Leidman, Eduardo Azziz Baumgartner, Anne von Gottberg, Jackie Kleynhans   +23 more
wiley   +2 more sources

Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study

The Lancet Microbe, 2023
Background Respiratory disease is a major cause of morbidity and mortality; however, surveillance for circulating respiratory viruses is passive and biased.
A. Boehm, Bridgette Hughes, D. Duong, V. Chan-Herur, Anna B. Buchman, M. Wolfe, B. White   +6 more
semanticscholar   +1 more source

Possible respiratory syncytial virus infection presenting as diffuse alveolar hemorrhage in an elderly treated with systemic corticosteroid: A case report

Respiratory Medicine Case Reports, 2021
Introduction: Respiratory syncytial virus infection is gaining interest in the elderly due to its growing morbidity and mortality. We present a Case of respiratory syncytial virus infection presenting as diffuse alveolar hemorrhage that was highly ...
Kyung Hun Nam, MD MPH, Junho Kang, MD, Younsuck Koh, MD PhD FCCM   +2 more
doaj   +1 more source

Respiratory Syncytial Virus Prevention within Reach: The Vaccine and Monoclonal Antibody Landscape

Lancet. Infectious Diseases (Print), 2022
Summary Respiratory syncytial virus (RSV) is the second most common cause of infant mortality and an important cause of morbidity and mortality in older adults. Efforts to develop an RSV vaccine or immunoprophylaxis remain highly active. Thirty-three RSV
N. Mazur, J. Terstappen, R. Baral, A. Bardají, P. Beutels, U. Buchholz, C. Cohen, J. Crowe, C. Cutland, Linda Eckert, D. Feikin, T. Fitzpatrick, Y. Fong, B. Graham, T. Heikkinen, Deborah Higgins, S. Hirve, K. Klugman, L. Kragten–Tabatabaie, P. Lemey, R. Libster, Y. Löwensteyn, A. Mejías, F. Muñoz, P. Munywoki, L. Mwananyanda, H. Nair, M. Nunes, O. Ramilo, P. Richmond, T. Ruckwardt, Charles J. Sande, P. Srikantiah, N. Thacker, Kody A. Waldstein, D. Weinberger, J. Wildenbeest, D. Wiseman, H. Zar, M. Zambon, L. Bont   +40 more
semanticscholar   +1 more source

The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review

Infection and Drug Resistance, 2023
Respiratory syncytial virus (RSV) is one of the most common respiratory viruses. It not only affects young children but also the elderly and immunocompromised patients. After the emergence of SARS-CoV-2 and the corona virus disease 2019 (COVID-19) era, a
Yu-Chuan Chuang, Kuan-Pei Lin, Li-An Wang, Ting-Kuang Yeh, Po-Yu Liu   +4 more
semanticscholar   +1 more source

Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series

EClinicalMedicine, 2021
Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection.
Yvette N Löwensteyn, Harish Nair, Marta C Nunes, Ichelle van Roessel, Femke S Vernooij, Joukje Willemsen, Louis J Bont, Natalie I Mazur   +7 more
doaj   +1 more source

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

Pathogens, 2023
Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults.
Xanthippi Topalidou, A. Kalergis, G. Papazisis   +2 more
semanticscholar   +1 more source

Assessment of Nurses' Awareness Regarding Respiratory Syncytial Virus [PDF]

Helwan International Journal for Nursing Research and Practice
Background: Respiratory syncytial virus is common respiratory virus that causes bronchiolitis and pneumonia, particularly in infants and older adults. Nurses, being on the frontlines of patient care, need to be well-informed about the virus, its symptoms,
Ahmed hussein
doaj   +1 more source

Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children

JAMA Network Open, 2023
This systematic review and network meta-analysis compares the efficacy and safety of 4 monoclonal antibodies for preventing respiratory syncytial virus among infants and children.
Mingyao Sun, H. Lai, Feiyang Na, Sheng Li, Xia Qiu, Jin-Hui Tian, Zhi-Gang Zhang, L. Ge   +7 more
semanticscholar   +1 more source